SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-071255
Filing Date
2019-12-10
Accepted
2019-12-10 11:19:58
Documents
7
Period of Report
2019-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1924763-1_8k.htm 8-K 27934
2 EXHIBIT 4.1 tm1924763d1_ex4-1.htm EX-4.1 89201
3 EXHIBIT 4.2 tm1924763d1_ex4-2.htm EX-4.2 93095
4 EXHIBIT 5.1 tm1924763d1_ex5-1.htm EX-5.1 8799
5 EXHIBIT 10.1 tm1924763d1_ex10-1.htm EX-10.1 215401
6 EXHIBIT 99.1 tm1924763d1_ex99-1.htm EX-99.1 11123
7 GRAPHIC tm1924763d1_ex5-1img01.jpg GRAPHIC 5049
  Complete submission text file 0001104659-19-071255.txt   453990
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 191276816
SIC: 2834 Pharmaceutical Preparations